Physician-related predictors of referral for multidisciplinary paediatric obesity management: a population-based

Nicole D Gehring1, Maryam Kebbe2, Sarah Rathwell3

  • 1Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.

Family Practice
|March 23, 2021
PubMed

Insights

Female physicians, pediatricians, and urban-based doctors are more likely to refer children with obesity to specialized management. Strategies are needed to increase referrals from male, family, and non-urban physicians for better pediatric obesity care.

Area of Science:

  • Public Health
  • Pediatrics
  • Health Services Research

Background:

  • Childhood overweight and obesity require effective management strategies.
  • Multidisciplinary paediatric obesity management is recommended for improving health outcomes.
  • Primary care physicians play a crucial role in referring children to these specialized services.

Purpose of the Study:

  • To identify factors associated with physician referrals to multidisciplinary paediatric obesity management.
  • To understand predictors influencing the decision-making process for paediatric obesity referrals.

Main Methods:

  • Retrospective, population-level study analyzing physician referral data in Alberta, Canada (2014-2017).
  • Inclusion criteria: Physicians referring children aged 2-17 with BMI ≥85th percentile.
  • Statistical analysis included univariable and multivariable logistic regression to identify referral predictors.

Main Results:

  • 35.2% of physicians referred at least one child for obesity management.
  • Female physicians (OR: 1.68), paediatricians (OR: 4.89), and urban-based physicians (OR: 2.17) showed significantly higher referral rates.
  • Referral likelihood varied based on physician demographics and practice location.

Conclusions:

  • Referral rates for paediatric obesity management are suboptimal, with approximately one-third of physicians participating.
  • Targeted interventions are necessary to enhance referral practices among male, family physicians, and non-urban-based physicians.
  • Improving referral consistency is vital for effective management of childhood obesity.
Abstract

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
84
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
73
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
69
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
85
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
893